Ultragenyx Pharmaceutical Inc.
RARE
$26.84
$0.542.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.26% | 59.91% | -12.78% | -1.39% | -18.94% |
| Total Receivables | -22.50% | 37.52% | -8.65% | 23.85% | -17.73% |
| Inventory | 5.77% | -0.38% | 12.26% | 1.01% | 2.29% |
| Prepaid Expenses | 23.91% | 16.19% | -19.71% | 4.09% | 57.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -38.46% | 32.30% | 8.75% | 6.58% | 21.10% |
| Total Current Assets | -30.91% | 47.85% | -10.64% | 2.95% | -14.42% |
|
|
|||||
| Total Current Assets | -30.91% | 47.85% | -10.64% | 2.95% | -14.42% |
| Net Property, Plant & Equipment | -10.49% | 6.82% | -2.27% | -1.97% | -10.65% |
| Long-term Investments | 0.00% | -0.91% | 0.00% | 0.00% | 0.92% |
| Goodwill | 0.00% | -0.91% | 0.00% | 0.00% | 0.92% |
| Total Other Intangibles | -1.14% | 1.77% | -1.02% | -1.01% | -0.83% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.86% | -36.05% | -3.76% | -3.61% | 68.58% |
| Total Assets | -15.40% | 28.69% | -8.87% | -0.43% | -12.71% |
|
|
|||||
| Total Accounts Payable | 35.48% | -23.59% | 18.49% | -27.84% | 21.67% |
| Total Accrued Expenses | -26.79% | 20.17% | 21.98% | 4.50% | -28.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.11% | 4.26% | 2.72% | 11.44% | 13.11% |
| Total Finance Division Other Current Liabilities | 142.86% | 466.34% | -52.11% | -22.91% | -16.30% |
| Total Other Current Liabilities | 142.86% | 466.34% | -52.11% | -22.91% | -16.30% |
| Total Current Liabilities | -15.36% | 12.93% | 15.95% | 0.54% | -15.21% |
|
|
|||||
| Total Current Liabilities | -15.36% | 12.93% | 15.95% | 0.54% | -15.21% |
| Long-Term Debt | -1.66% | 50.18% | -2.43% | -1.42% | -3.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 10.64% | -11.58% | -11.71% | -7.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.00% | 2.38% | 2.91% | 0.58% | 0.39% |
| Total Liabilities | -4.98% | 36.68% | 2.29% | -1.09% | -6.47% |
|
|
|||||
| Common Stock & APIC | 0.67% | 0.89% | 0.85% | 2.87% | 0.94% |
| Retained Earnings | -4.08% | -2.92% | -4.27% | -2.80% | -3.81% |
| Treasury Stock & Other | -100.00% | 21.95% | 405.97% | 21.41% | 65.90% |
| Total Common Equity | -195.00% | -973.46% | -93.95% | 4.88% | -43.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -195.00% | -973.46% | -93.95% | 4.88% | -43.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Equity | -213.70% | -551.76% | -89.79% | 4.65% | -42.27% |
|
|
|||||